Richard A. Miller MD - 07 May 2025 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role: President and CEO, Director
Signature: /s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller
Issuer symbol: CRVS
Transactions as of: 07 May 2025
Net transactions value: +$1,956,756
Form type: 4
Filing time: 09 May 2025, 16:09:21 UTC
Previous filing: 23 Dec 2024
Next filing: 08 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
MILLER RICHARD A MD	President and CEO, Director	C/O CORVUS PHARMACEUTICALS, INC., 901 GATEWAY BOULEVARD, THIRD FLOOR, SOUTH SAN FRANCISCO	/s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller	09 May 2025	0001031847

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRVS	Common Stock	Options Exercise	$1,956,756	+559,073	+97%	$3.50	1,136,707	07 May 2025	Direct
holding	CRVS	Common Stock						1,188,103	07 May 2025	By Trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRVS	Warrant (Right to Buy)	Options Exercise		-559,073	-100%		0	07 May 2025	Common Stock	559,073	$3.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
F2	Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.